GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Antibody
Comment: LY2928057 is an investigational anti-ferroportin monoclonal being developed as a treatment for anemia. A search of patents reveals WO2010065496 A1 as Eli Lilly's application covering the development and use of anti-ferroportin 1 monoclonal antibodies [1]. The HGNC approved gene symbol for ferroportin 1 is SLC40A1.
|
